Empowering Biomedical Innovation to Safeguard Human Health

Backing breakthrough therapeutics that matter to patients worldwide.

A disciplined investment philosophy paired with hands-on, full-lifecycle empowerment.

Here is your Hankang

Hankang Capital is a specialist investor dedicated to the innovative biotechnology sector. Driven by deep industry insight and a rigorous investment methodology, we identify and support top-tier teams developing inflection-point candidates across diverse modalities to deliver significant clinical value...

Therapeutic Area Focus

Oncology

Immunology

Cardiovascular & Metabolic Diseases

Neuroscience & Psychiatry

Infectious Diseases

Diversified Investment in Global Healthcare Innovation

By consistently nurturing early-stage breakthroughs into world-class therapies, we serve as a devoted cultivator empowering biomedical innovation for the benefit of patients worldwide.

Read more

Hankang Ecosytem

Our portfolio is globally recognized for its scientific and technological excellence, having forged extensive out-licensing collaborations and co-development partnerships with leading multinational corporations (MNCs). Our team and advisory network bring extensive hands-on expertise in drug discovery, clinical development, regulatory affairs (NMPA & FDA), business development and commercialization.